What is the share price of Cian Healthcare Ltd (CHCL) today?
The share price of CHCL as on 21st March 2025 is ₹3.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Cian Healthcare Ltd (CHCL) share?
The past returns of Cian Healthcare Ltd (CHCL) share are- Past 1 week: -4.52%
- Past 1 month: -3.55%
- Past 3 months: -12.44%
- Past 6 months: -30.15%
- Past 1 year: -82.02%
- Past 3 years: -78.29%
- Past 5 years: -74.67%
What are the peers or stocks similar to Cian Healthcare Ltd (CHCL)?
The peers or stocks similar to Cian Healthcare Ltd (CHCL) include:What is the market cap of Cian Healthcare Ltd (CHCL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Cian Healthcare Ltd (CHCL) is ₹9.50 Cr as of 21st March 2025.What is the 52 week high and low of Cian Healthcare Ltd (CHCL) share?
The 52-week high of Cian Healthcare Ltd (CHCL) is ₹26.50 and the 52-week low is ₹2.97.What is the PE and PB ratio of Cian Healthcare Ltd (CHCL) stock?
The P/E (price-to-earnings) ratio of Cian Healthcare Ltd (CHCL) is 37.99. The P/B (price-to-book) ratio is 0.16.Which sector does Cian Healthcare Ltd (CHCL) belong to?
Cian Healthcare Ltd (CHCL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Cian Healthcare Ltd (CHCL) shares?
You can directly buy Cian Healthcare Ltd (CHCL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Cian Healthcare Ltd
CHCL Share Price
3.800.00% (+0.00)
CHCL Share Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
CHCL Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 0.16 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
50.00 | 6.39 | 0.53% |
CHCL Analyst Ratings & Forecast
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
CHCL Company Profile
Cian Healthcare Limited is a transnational manufacturing Company with wide range of pharmaceutical, nutraceutical, ayurvedic, cosmeceuticals, sexual wellness and food supplement products.
CHCL Similar Stocks (Peers)
Compare with peersSUNPHARMA
PE Ratio
44.71
1Y Return
14.01%
Buy Reco %
88.24
CIPLA
PE Ratio
29.86
1Y Return
5.19%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
65.86
1Y Return
26.18%
Buy Reco %
68.00
DRREDDY
PE Ratio
17.93
1Y Return
2.08%
Buy Reco %
45.16
MANKIND
PE Ratio
52.09
1Y Return
13.24%
Buy Reco %
80.00
CHCL Forecasts
Price
Revenue
Earnings
CHCL Share Price Forecast
CHCL Company Revenue Forecast
CHCL Stock EPS (Earnings Per Share) Forecast
CHCL
Income
Balance Sheet
Cash Flow
Annual Normal View
CHCL Income Statement
Annual Normal View
Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 57.95 | 74.01 | 78.41 | 69.32 | 62.82 | — | ||||||
Raw Materials | 27.37 | 39.41 | 54.79 | 36.49 | 41.12 | — | ||||||
Power & Fuel Cost | 0.09 | 0.05 | 0.06 | 0.07 | 0.07 | |||||||
Employee Cost | 4.04 | 6.68 | 9.37 | 8.86 | 8.12 | |||||||
Selling & Administrative Expenses | 4.36 | 4.50 | 5.08 | 5.03 | 4.52 | |||||||
Operating & Other expenses | 13.95 | 11.31 | 4.29 | 5.15 | -2.53 | |||||||
EBITDA | 8.14 | 12.06 | 4.82 | 13.72 | 11.52 | — | ||||||
Depreciation/Amortization | 4.45 | 3.45 | 4.27 | 5.43 | 5.47 | — | ||||||
PBIT | 3.69 | 8.61 | 0.55 | 8.29 | 6.05 | — | ||||||
Interest & Other Items | 7.22 | 7.92 | 6.55 | 6.30 | 6.00 | — | ||||||
PBT | -3.53 | 0.69 | -6.00 | 1.99 | 0.05 | — | ||||||
Taxes & Other Items | 0.26 | 0.63 | -0.47 | -0.04 | -0.20 | — | ||||||
Net Income | -3.79 | 0.06 | -5.53 | 2.03 | 0.25 | — | ||||||
EPS | -1.62 | 0.03 | -2.29 | 0.81 | 0.10 | — | ||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
CHCL Company Updates
FY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFCHCL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Cian Healthcare Ltd | 37.99 | 0.16 | — |
Sun Pharmaceutical Industries Ltd | 44.71 | 6.38 | 0.76% |
Cipla Ltd | 29.86 | 4.59 | 0.85% |
Torrent Pharmaceuticals Ltd | 65.86 | 15.91 | 0.87% |
CHCL Stock Price Comparison
Compare CHCL with any stock or ETFCompare CHCL with any stock or ETF
CHCL
CHCL Shareholdings
CHCL Promoter Holdings Trend
CHCL Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 3.73%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
CHCL Shareholding Pattern
CHCL Shareholding History
Foreign Institutions
smallcases containing CHCL stock
Looks like this stock is not in any smallcase yet.
CHCL Events
CHCL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CHCL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
CHCL Dividends
CHCL Stock News & Opinions
Articles & Videos
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant